trial · primary record
Clemizole HCl
Dravet Syndrome
| Phase | Phase 3 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 150 |
| Primary completion | 2029-05 |
| Primary endpoint | Percent Change in Countable Motor Seizures Per 28 Days (CMS-28) in the Titration Plus Maintenance Periods Relative to Baseline |
| Registry ID | NCT04462770 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-29T14:34:28.323Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT04462770
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.